Form 8-K - Current report:
SEC Accession No. 0001104659-25-002843
Filing Date
2025-01-13
Accepted
2025-01-13 07:03:53
Documents
19
Period of Report
2025-01-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm251420d1_8k.htm   iXBRL 8-K 75811
2 EXHIBIT 2.1 tm251420d1_ex2-1.htm EX-2.1 757691
3 EXHIBIT 10.1 tm251420d1_ex10-1.htm EX-10.1 54823
4 EXHIBIT 99.1 tm251420d1_ex99-1.htm EX-99.1 68509
5 EXHIBIT 99.2 tm251420d1_ex99-2.htm EX-99.2 43147
9 GRAPHIC tm251420d1_ex99-1img001.jpg GRAPHIC 4551
10 GRAPHIC tm251420d1_ex99-1img002.jpg GRAPHIC 3829
  Complete submission text file 0001104659-25-002843.txt   1395011

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA enfn-20250110.xsd EX-101.SCH 3015
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE enfn-20250110_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enfn-20250110_pre.xml EX-101.PRE 22359
22 EXTRACTED XBRL INSTANCE DOCUMENT tm251420d1_8k_htm.xml XML 3801
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40949 | Film No.: 25524751
SIC: 7372 Services-Prepackaged Software
(CF Office: 06 Technology)